STIGALL L. JEREMY bought CLPT
February 17, 2026 · Form 4 insider transaction
STIGALL L. JEREMY bought 51,546 shares of ClearPoint Neuro, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,546
Price
$0.00
Total value
N/A
InsiderSTIGALL L. JEREMY
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after51,546
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.; The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029.